z-logo
open-access-imgOpen Access
MicroRNA-892a regulates laryngocarcinoma cell proliferation via Dicer
Author(s) -
Jinhui Dong,
Jianxin Wang,
Chunguang Shan,
Haizhong Zhang,
Xiaohong Ou
Publication year - 2020
Publication title -
experimental biology and medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 146
eISSN - 1535-3702
pISSN - 1535-3699
DOI - 10.1177/1535370220934036
Subject(s) - dicer , gene silencing , microrna , cancer research , cell growth , biology , cancer cell , cancer , apoptosis , flow cytometry , small interfering rna , cell culture , microbiology and biotechnology , transfection , genetics , gene
This work expanded the knowledge of the molecular mechanisms underlying LC progression by exploring the role of miR-892a in the viability of TU212 and M4E cells. The results showed that miR-892a, which exhibited elevated expression in LC cells and tissue specimens of patients with LC, exerted an inhibitory effect on Dicer expression, whereas silencing of miR-892a in TU212 and M4E cells hindered cell proliferation and growth and promoted apoptosis. Furthermore, miR-892a was demonstrated to directly target Dicer 3'-UTR and inhibit its expression. These findings demonstrated that miR-892a acted as an LC oncogene via its action on Dicer, which further confirmed that miR-892a can serve as a diagnostic indicator or promising agent for LC treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here